Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate that patients with Spondylarthropathies in remission under antiTNF therapy, can maintain the remission with a maintenance dose inferior to the currently recommended dose schedule.


Clinical Trial Description

It has been shown that the withdrawal of treatment follows with a flare of the disease in a short time after the suspension but it has not been evaluated in controlled trials if remission could be maintained with a lower dose. A multicenter, national, open-label, randomized and controlled clinical trial of 3 years duration (2 years for inclusion + 1 year follow-up) is proposed to address this issue. The study will include 190 patients with Spondylarthropathies in stable treatment with any single anti-TNF agent and compliance with criteria of clinical remission for at least 4 months. Patients will be randomized to intervention or control arm, with stratification according to the antiTNF product thet were receiving prior to inclusion. Patients will be followed with the calendar of visits recommended by the Spanish Society of Rheumatology for clinical practice. The proposed hypothesis is of non-inferiority of the experimental arm with dose reduction versus the control arm with standard treatment. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01604629
Study type Interventional
Source Spanish Clinical Pharmacology Society
Contact
Status Completed
Phase Phase 4
Start date July 2012
Completion date September 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04540432 - Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment N/A
Completed NCT03173144 - Chronic Inflammatory Disease, Lifestyle and Treatment Response
Recruiting NCT01216631 - Seronegative Oligoarthritis of the Knee Study (SOKS) Phase 2
Completed NCT00133315 - TNFalfa Blocking Treatment of Spondylarthropathies Phase 4
Active, not recruiting NCT03456206 - Chronic Inflammatory Disease, Lifestyle and Risk of Disease
Completed NCT02436785 - Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? N/A
Completed NCT03358134 - Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis Phase 3
Withdrawn NCT00298012 - Methotrexate in the Treatment of Axial Spondyloarthritis Phase 4
Recruiting NCT02809781 - A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis Phase 2/Phase 3
Completed NCT02098694 - Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis N/A
Completed NCT00591201 - Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies Phase 2/Phase 3
Completed NCT03190603 - Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis Phase 4
Active, not recruiting NCT06402396 - Assessing Pain by the painDETECT Questionnaire (PDQ)
Completed NCT04709354 - Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails